NCT04704154 2025-04-18A Trial to Learn Whether Regorafenib in Combination With Nivolumab Can Improve Tumor Responses and How Safe it is for Participants With Solid TumorsBayerPhase 2 Completed175 enrolled 20 charts
NCT03278626 2022-03-28Immune Checkpoint Therapy With Nivolumab Esophageal Squamous Cell CarcinomaNYU Langone HealthPhase 1/2 Terminated12 enrolled 8 charts